Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Rossi

Showing results (11-20 of 245) with videos related to

Pageof 25
Sort By:
Prion|October 25, 2012
Astrocyte signaling and neurodegeneration: new insights into CNS disordersLiliana Brambilla, Francesca Martorana, Daniela Rossi
Cells|April 3, 2021
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?Giulia Guidotti, Chiara Scarlata, Liliana Brambilla, et al.
Autoimmunity Reviews|August 6, 2017
How I treat patients with adult onset Still's disease in clinical practiceMarcello Govoni, Alessandra Bortoluzzi, Daniela Rossi, et al.
Drugs|February 2, 2023
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological ManagementDario Roccatello, Savino Sciascia, Daniela Rossi, et al.
Neural Plasticity|August 13, 2015
Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the AstrocytesFrancesca Martorana, Giulia Guidotti, Liliana Brambilla, et al.
Current Opinion in Pharmacology|January 6, 2023
Store-operated calcium entry: From physiology to tubular aggregate myopathyFeliciano Protasi, Barbara Girolami, Sara Roccabianca, et al.
Frontiers in Neuroscience|September 14, 2018
Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral SclerosisLiliana Brambilla, Francesca Martorana, Giulia Guidotti, et al.
Expert Opinion on Therapeutic Targets|August 1, 2017
The potential of obscurin as a therapeutic target in muscle disordersDavide Randazzo, Enrico Pierantozzi, Daniela Rossi, et al.
International Review of Neurobiology|August 7, 2007
Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammationSabino Vesce, Daniela Rossi, Liliana Brambilla, et al.
International Immunopharmacology|April 4, 2015
Rheumatoid arthritis: Biological therapy other than anti-TNFDaniela Rossi, Vittorio Modena, Savino Sciascia, et al.
Pageof 25

Showing results (11-20 of 245) with videos related to

Sort By:
Pageof 25
Prion|October 25, 2012
Astrocyte signaling and neurodegeneration: new insights into CNS disordersLiliana Brambilla, Francesca Martorana, Daniela Rossi
Cells|April 3, 2021
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?Giulia Guidotti, Chiara Scarlata, Liliana Brambilla, et al.
Autoimmunity Reviews|August 6, 2017
How I treat patients with adult onset Still's disease in clinical practiceMarcello Govoni, Alessandra Bortoluzzi, Daniela Rossi, et al.
Drugs|February 2, 2023
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological ManagementDario Roccatello, Savino Sciascia, Daniela Rossi, et al.
Neural Plasticity|August 13, 2015
Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the AstrocytesFrancesca Martorana, Giulia Guidotti, Liliana Brambilla, et al.
Current Opinion in Pharmacology|January 6, 2023
Store-operated calcium entry: From physiology to tubular aggregate myopathyFeliciano Protasi, Barbara Girolami, Sara Roccabianca, et al.
Frontiers in Neuroscience|September 14, 2018
Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral SclerosisLiliana Brambilla, Francesca Martorana, Giulia Guidotti, et al.
Expert Opinion on Therapeutic Targets|August 1, 2017
The potential of obscurin as a therapeutic target in muscle disordersDavide Randazzo, Enrico Pierantozzi, Daniela Rossi, et al.
International Review of Neurobiology|August 7, 2007
Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammationSabino Vesce, Daniela Rossi, Liliana Brambilla, et al.
International Immunopharmacology|April 4, 2015
Rheumatoid arthritis: Biological therapy other than anti-TNFDaniela Rossi, Vittorio Modena, Savino Sciascia, et al.
Pageof 25